BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31680021)

  • 1. Spatial clusters of Clostridium difficile infection and an association with neighbourhood socio-economic disadvantage in the Australian Capital Territory, 2004-2014.
    Lal A; Swaminathan A; Holani T
    Infect Dis Health; 2020 Feb; 25(1):3-10. PubMed ID: 31680021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses.
    Anderson DJ; Rojas LF; Watson S; Knelson LP; Pruitt S; Lewis SS; Moehring RW; Sickbert Bennett EE; Weber DJ; Chen LF; Sexton DJ;
    PLoS One; 2017; 12(5):e0176285. PubMed ID: 28510584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to: Surveillance of Clostridium difficile infections.
    Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
    Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory-based surveillance of Clostridium difficile strains circulating in the Australian healthcare setting in 2012.
    Collins DA; Putsathit P; Elliott B; Riley TV
    Pathology; 2017 Apr; 49(3):309-313. PubMed ID: 28237369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
    Kato H; Senoh M; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102011. PubMed ID: 30872073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Clostridium difficile infections in Australia: enhanced surveillance to evaluate time trends and severity of illness in Victoria, 2010-2014.
    Worth LJ; Spelman T; Bull AL; Brett JA; Richards MJ
    J Hosp Infect; 2016 Jul; 93(3):280-5. PubMed ID: 27107622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribotype 078 Clostridium difficile infection incidence in Dutch hospitals is not associated with provincial pig farming: Results from a national sentinel surveillance, 2009-2015.
    van Dorp SM; de Greeff SC; Harmanus C; Sanders IMJG; Dekkers OM; Knetsch CW; Kampinga GA; Notermans DW; Kuijper EJ
    PLoS One; 2017; 12(12):e0189183. PubMed ID: 29287077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.
    Zilberberg MD; Tabak YP; Sievert DM; Derby KG; Johannes RS; Sun X; McDonald LC
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):649-55. PubMed ID: 21666394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based spatio-temporal analysis of Clostridium difficile infection in Queensland, Australia over a 10-year period.
    Furuya-Kanamori L; Robson J; Soares Magalhães RJ; Yakob L; McKenzie SJ; Paterson DL; Riley TV; Clements AC
    J Infect; 2014 Nov; 69(5):447-55. PubMed ID: 24984276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012.
    Slimings C; Armstrong P; Beckingham WD; Bull AL; Hall L; Kennedy KJ; Marquess J; McCann R; Menzies A; Mitchell BG; Richards MJ; Smollen PC; Tracey L; Wilkinson IJ; Wilson FL; Worth LJ; Riley TV
    Med J Aust; 2014 Mar; 200(5):272-6. PubMed ID: 24641152
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Legenza L; Barnett S; Rose W; Safdar N; Emmerling T; Peh KH; Coetzee R
    Antimicrob Resist Infect Control; 2018; 7():125. PubMed ID: 30386594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
    Longtin Y; Paquet-Bolduc B; Gilca R; Garenc C; Fortin E; Longtin J; Trottier S; Gervais P; Roussy JF; Lévesque S; Ben-David D; Cloutier I; Loo VG
    JAMA Intern Med; 2016 Jun; 176(6):796-804. PubMed ID: 27111806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011.
    Marufu O; Desai N; Aldred D; Brown T; Eltringham I
    J Hosp Infect; 2015 Jan; 89(1):38-45. PubMed ID: 25480022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.
    Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A
    Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus.
    Clohessy P; Merif J; Post JJ
    Int J Infect Dis; 2014 Dec; 29():152-5. PubMed ID: 25449250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing for Clostridium difficile in patients newly diagnosed with inflammatory bowel disease in a community setting.
    Krishnarao A; de Leon L; Bright R; Moniz H; Law M; Leleiko N; Sands BE; Merrick M; Shapiro J; Wallenstein S; Giacalone J; Shah SA
    Inflamm Bowel Dis; 2015 Mar; 21(3):564-9. PubMed ID: 25581825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
    Novakova E; Stefkovicova M; Kopilec MG; Novak M; Kotlebova N; Kuijper E; Krutova M
    Int J Infect Dis; 2020 Jan; 90():111-115. PubMed ID: 31707136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.